Regeneron Pharmaceuticals Inc.
Regeneron is a genetically‑based biopharma focused on high‑margin therapies like the eye drug EYLEA and atopic dermatitis therapy Dupixent, partnering with Sanofi, Bayer, and Teva while advancing CRISPR platforms.
Headquarters: United States (USA)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Professional Services
- Industry: Biotechnology Research
- Employees: 15,222
- HQ: Tarrytown
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.